An Integrated In Vitro 3D Model of Human Bone Marrow and Peripheral Infection
Project Number5R01EB030410-04
Former Number1R01EB030410-01
Contact PI/Project LeaderGEORGE, STEVEN CARL
Awardee OrganizationUNIVERSITY OF CALIFORNIA AT DAVIS
Description
Abstract Text
PROJECT SUMMARY
The immune response to a peripheral infection is a fundamental feature of the human immune system,
providing robust protection from a myriad of infectious agents. The response necessarily invokes the innate
immune system, but many features of this orchestrated response are poorly understood, limiting our ability to
augment the response to new and ever evolving threats. In particular, the innate response engages the bone
marrow to modify the magnitude and dynamics of the response. There are important differences between the
mouse (primary model to study the innate immune response) and human innate immune responses, in
particular scale and dynamics, and new technologies in 3D cell and tissue culture provide exciting
opportunities in the field known as “organ-on-a-chip”. The primary goal of this project is to design, build, and
validate an integrated human “ImmuneChip” platform that mimics key dynamic features of the production and
trafficking of polymorphonuclear leukocytes (PMN, i.e., neutrophils) between the bone marrow, systemic
circulation, and peripheral site of bacterial infection. Developing this technology is important because of the
alarming expansion of antibiotic resistance bacteria which will demand creative and alternative approaches to
combat. The specific aims are to: 1) design, build, and test a microfluidic ImmuneChip that simulates the
homeostatic interaction between bone marrow, systemic circulation, and a sterile skin model; 2) establish a
homeostatic circuit in the ImmuneChip in which HSPC expansion, PMN trafficking, and antimicrobial defenses
respond to soluble mediators of bacterial infection; and 3) demonstrate an appropriate response to contain a
methicillin-resistant (and sensitive) S. aureus peripheral infection within the ImmuneChip, and produce a test-
bed for novel biological strategies to combat infection. The in vitro model will be able to uniquely simulate the
dynamics of peripheral infection-bone marrow communication including transport barriers, residence time in
the circulation, and dilution due to the large difference in the size of the compartments. Accomplishing our
primary goal will create a technology that advances a new class of model systems to understand the human
response to peripheral infection.
Public Health Relevance Statement
PROJECT NARRATIVE
The central objective of our proposal is to design, build, and validate an integrated human “ImmuneChip”
platform that mimics key dynamic features of the production and trafficking of white blood cells between the bone
marrow, systemic circulation, and peripheral site of bacterial infection. The results of the project will create a
technology that advances a new class of model systems to understand the innate immune response to infection.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
047120084
UEI
TX2DAGQPENZ5
Project Start Date
15-September-2021
Project End Date
31-May-2025
Budget Start Date
01-June-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$585,004
Direct Costs
$412,179
Indirect Costs
$172,825
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$585,004
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB030410-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB030410-04
Patents
No Patents information available for 5R01EB030410-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB030410-04
Clinical Studies
No Clinical Studies information available for 5R01EB030410-04
News and More
Related News Releases
No news release information available for 5R01EB030410-04
History
No Historical information available for 5R01EB030410-04
Similar Projects
No Similar Projects information available for 5R01EB030410-04